What is CM-4307 used for?

CM-4307 is being studied as a potential treatment for several cancers, including thyroid, pancreatic, and lung cancer.

Is CM-4307 an approved drug?

No, CM-4307 is still in the clinical trial phase and has not received full approval for use.

What kind of cancer can CM-4307 treat?

Research is looking into how CM-4307 might help with thyroid cancer, pancreatic cancer, and liver cancer.

Can CM-4307 be used for lung cancer?

Clinical studies are investigating CM-4307 for use in non-small cell lung carcinoma.

Is CM-4307 a small molecule?

Yes, CM-4307 is classified as a small molecule drug.

What stage of testing is CM-4307 in?

CM-4307 has reached Phase 3 clinical trials for certain indications like thyroid cancer.

donafenib | CAS 1130115-44-4 | MLDQJTXFUGDVEO

Loading compound...

Small molecule cancer research drug

CM-4307 is a small molecule drug currently being studied in clinical trials. It is primarily being investigated for its potential to treat various types of cancer, including thyroid cancer and pancreatic cancer.

Used for

Thyroid cancerPancreatic cancerBiliary tract cancerCholangiocarcinomaHepatocellular carcinomaAcute myeloid leukemiaNon-small cell lung carcinoma

Conditions

Cancer

Class

Small moleculeAntineoplasticSmall molecule cancer research drugEndocrine systemDigestive systemRespiratory systemHematologic system

How to take

CM-4307 is currently in the research and clinical trial stages and is not yet an approved medication for general use.

Talk to your doctor

Questions to ask

·Is CM-4307 part of a clinical trial I can join?
·How does CM-4307 differ from my current cancer treatment?
·What are the expected risks of CM-4307?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)